170 related articles for article (PubMed ID: 34675552)
1. Persistent Eosinophilic Inflammation in Adult Asthmatics with High Serum and Urine Levels of Leukotriene E
Ban GY; Kim SH; Park HS
J Asthma Allergy; 2021; 14():1219-1230. PubMed ID: 34675552
[TBL] [Abstract][Full Text] [Related]
2. Association of eosinophil-derived neurotoxin levels with asthma control status in patients with aspirin-exacerbated respiratory disease.
Ban GY; Yang EM; Ye YM; Park HS
Clin Transl Allergy; 2023 Mar; 13(3):e12229. PubMed ID: 36973950
[TBL] [Abstract][Full Text] [Related]
3. Effect of TGF-β1 on eosinophils to induce cysteinyl leukotriene E4 production in aspirin-exacerbated respiratory disease.
Choi Y; Sim S; Lee DH; Lee HR; Ban GY; Shin YS; Kim YK; Park HS
PLoS One; 2021; 16(8):e0256237. PubMed ID: 34437574
[TBL] [Abstract][Full Text] [Related]
4. Differences in urinary leukotriene E4 levels and distribution of eosinophils between chronic rhinosinusitis patients with aspirin-intolerant and -tolerant asthma.
Yamaguchi T; Ishii T; Yamamoto K; Higashi N; Taniguchi M; Okamoto M
Auris Nasus Larynx; 2016 Jun; 43(3):304-8. PubMed ID: 26527517
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic analysis identifies potential diagnostic biomarkers for aspirin-exacerbated respiratory disease.
Ban GY; Cho K; Kim SH; Yoon MK; Kim JH; Lee HY; Shin YS; Ye YM; Cho JY; Park HS
Clin Exp Allergy; 2017 Jan; 47(1):37-47. PubMed ID: 27533637
[TBL] [Abstract][Full Text] [Related]
6. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.
Mastalerz L; Celejewska-Wójcik N; Wójcik K; Gielicz A; Januszek R; Cholewa A; Stręk P; Sanak M
Allergy; 2014 Nov; 69(11):1550-9. PubMed ID: 25123806
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical outcomes of aspirin-exacerbated respiratory disease: Real-world data from an adult asthma cohort.
Lee Y; Kim C; Lee E; Lee HY; Woo SD; You SC; Park RW; Park HS
Clin Exp Allergy; 2023 Sep; 53(9):941-950. PubMed ID: 37332228
[TBL] [Abstract][Full Text] [Related]
8. Aspirin provocation increases 8-iso-PGE2 in exhaled breath condensate of aspirin-hypersensitive asthmatics.
Mastalerz L; Januszek R; Kaszuba M; Wójcik K; Celejewska-Wójcik N; Gielicz A; Plutecka H; Oleś K; Stręk P; Sanak M
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):163-9. PubMed ID: 26209241
[TBL] [Abstract][Full Text] [Related]
9. The use of leukotriene receptor antagonists (LTRAs) as complementary therapy in asthma.
Bjermer L; Diamant Z
Monaldi Arch Chest Dis; 2002 Feb; 57(1):76-83. PubMed ID: 12174707
[TBL] [Abstract][Full Text] [Related]
10. The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease.
Comhair SAA; Bochenek G; Baicker-McKee S; Wang Z; Stachura T; Sanak M; Hammel JP; Hazen SL; Erzurum SC; Nizankowska-Mogilnicka E
Respir Res; 2018 Oct; 19(1):210. PubMed ID: 30376852
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Accuracy of Urinary LTE4 Measurement to Predict Aspirin-Exacerbated Respiratory Disease in Patients with Asthma.
Bochenek G; Stachura T; Szafraniec K; Plutecka H; Sanak M; Nizankowska-Mogilnicka E; Sladek K
J Allergy Clin Immunol Pract; 2018; 6(2):528-535. PubMed ID: 28888846
[TBL] [Abstract][Full Text] [Related]
12. Leukotriene E
Lazarinis N; Bood J; Gomez C; Kolmert J; Lantz AS; Gyllfors P; Davis A; Wheelock CE; Dahlén SE; Dahlén B
J Allergy Clin Immunol; 2018 Oct; 142(4):1080-1089. PubMed ID: 29518425
[TBL] [Abstract][Full Text] [Related]
13. Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.
Steinke JW; Liu L; Huyett P; Negri J; Payne SC; Borish L
J Allergy Clin Immunol; 2013 Oct; 132(4):856-65.e1-3. PubMed ID: 23806637
[TBL] [Abstract][Full Text] [Related]
14. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.
Bochenek G; Kuschill-Dziurda J; Szafraniec K; Plutecka H; Szczeklik A; Nizankowska-Mogilnicka E
J Allergy Clin Immunol; 2014 Jan; 133(1):98-103.e1-6. PubMed ID: 23993879
[TBL] [Abstract][Full Text] [Related]
15. Epithelial folliculin enhances airway inflammation in aspirin-exacerbated respiratory disease.
Trinh HKT; Pham DL; Choi Y; Kim HM; Kim SH; Park HS
Clin Exp Allergy; 2018 Nov; 48(11):1464-1473. PubMed ID: 30126026
[TBL] [Abstract][Full Text] [Related]
16. Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD.
Choi GS; Kim JH; Shin YS; Ye YM; Kim SH; Park HS
Clin Exp Allergy; 2013 Jul; 43(7):730-40. PubMed ID: 23786280
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics.
Kumlin M; Dahlén B; Björck T; Zetterström O; Granström E; Dahlén SE
Am Rev Respir Dis; 1992 Jul; 146(1):96-103. PubMed ID: 1320824
[TBL] [Abstract][Full Text] [Related]
18. Update on recent advances in the management of aspirin exacerbated respiratory disease.
Palikhe NS; Kim JH; Park HS
Yonsei Med J; 2009 Dec; 50(6):744-50. PubMed ID: 20046412
[TBL] [Abstract][Full Text] [Related]
19. Aspirin induced asthma (AIA) with nasal polyps has the highest basal LTE4 excretion: a study vs AIA without polyps, mild topic asthma, and normal controls.
Micheletto C; Visconti M; Tognella S; Facchini FM; Dal Negro RW
Eur Ann Allergy Clin Immunol; 2006 Jan; 38(1):20-3. PubMed ID: 16544584
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of serine palmitoyl transferase and ORMDL3 polymorphism are associated with eosinophilic inflammation and airflow limitation in aspirin-exacerbated respiratory disease.
Ban GY; Youn DY; Ye YM; Park HS
PLoS One; 2020; 15(10):e0240334. PubMed ID: 33031402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
